Abstract:Per capita fructose consumption has increased 100-fold over the last century<a href="/articles/s42255-020-0222-9#ref-CR1">1</a>. Epidemiological studies suggest that excessive fructose consumption, and especially consumption of sweet drinks, is associated with hyperlipidaemia, non-alcoholic fatty liver disease, obesity and diabetes<a href="#ref-CR2">2</a>,<a href="#ref-CR3">3</a>,<a href="#ref-CR4">4</a>,<a href="#ref-CR5">5</a>,<a href="#ref-CR6">6</a>,<a href="/articles/s42255-020-0222-9#ref-CR7">7</a>. Fructose metabolism begins with its phosphorylation by the enzyme ketohexokinase (KHK), which exists in two alternatively spliced forms<a href="/articles/s42255-020-0222-9#ref-CR8">8</a>. The more active isozyme, KHK-C, is expressed most strongly in the liver, but also substantially in the small intestine<a href="/articles/s42255-020-0222-9#ref-CR9">9</a>,<a href="/articles/s42255-020-0222-9#ref-CR10">10</a> where it drives dietary fructose absorption and conversion into other metabolites before fructose reaches the liver<a href="#ref-CR11">11</a>,<a href="#ref-CR12">12</a>,<a href="/articles/s42255-020-0222-9#ref-CR13">13</a>. It is unclear whether intestinal fructose metabolism prevents or contributes to fructose-induced lipogenesis and liver pathology. Here we show that intestinal fructose catabolism mitigates fructose-induced hepatic lipogenesis. In mice, intestine-specific KHK-C deletion increases dietary fructose transit to the liver and gut microbiota and sensitizes mice to fructose's hyperlipidaemic effects and hepatic steatosis. In contrast, intestine-specific KHK-C overexpression promotes intestinal fructose clearance and decreases fructose-induced lipogenesis. Thus, intestinal fructose clearance capacity controls the rate at which fructose can be safely ingested. Consistent with this, we show that the same amount of fructose is more strongly lipogenic when drunk than eaten, or when administered as a single gavage, as opposed to multiple doses spread over 45 min. Collectively, these data demonstrate that fructose induces lipogenesis when its dietary intake rate exceeds the intestinal clearance capacity. In the modern context of ready food availability, the resulting fructose spillover drives metabolic syndrome. Slower fructose intake, tailored to intestinal capacity, can mitigate these consequences.

Fructose regulates the pentose phosphate pathway and induces an inflammatory and resolution phenotype in Kupffer cells

Regulation of Fructose Metabolism in Nonalcoholic Fatty Liver Disease

Fructose stimulated de novo lipogenesis is promoted by inflammation

Fructose reprogrammes glutamine-dependent oxidative metabolism to support LPS-induced inflammation

High-Fructose Diet Increases Inflammatory Cytokines and Alters Gut Microbiota Composition in Rats

Fructose and the Liver

Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol‐Inducible Cytochrome P450‐2E1–Mediated Oxidative and Nitrative Stress

Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease

Fructose induced KHK-C can increase ER stress independent of its effect on lipogenesis to drive liver disease in diet-induced and genetic models of NAFLD

Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate

Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease

Fructose: a modulator of intestinal barrier function and hepatic health?

Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease

Fructose and carbonyl metabolites as endogenous toxins

Lipogenic Transcription Factor ChREBP Mediates Fructose-Induced Metabolic Adaptations to Prevent Hepatotoxicity

The chronic consumption of dietary fructose promotes the gut Clostridium species imbalance and bile acid alterations in developing nonalcoholic fatty liver disease

1849-P: Fructose Induces Hepatic Steatosis via ME1-Mediated Cytosolic Redox Status

The small intestine shields the liver from fructose-induced steatosis

Fructose selectively modulates c-jun N-terminal kinase activity and insulin signaling in rat primary hepatocytes

Dietary fructose improves intestinal cell survival and nutrient absorption

CD38 Inhibition Protects Fructose-Induced Toxicity in Primary Hepatocytes